Supplement to Petition to the FDA to ban the antidepressant drug nefazadone (SERZONE)

Public Citizen sent a petition to the the FDA in support of banning Serzone, an antidepressant, approved by the FDA in 1994, which has been known to cause liver toxicity and several deaths around the world.  In addition Public Citizen sent a supplement to that petition which you may read online.  They state that Canada, Europe and Scandanavia had banned the drug in 2003.  The article was written in 2003, but to date, Serzone is still on the market in the U.S.  The FDA only made the makers of Serzone, Bristol Myers Squibb Company, place a warning of life-threatening (liver) failure on the drug. Read the rest of this entry »


The Proven Dangers of Antidepressants

On March 22, 2004 the FDA issued an extraordinary “Public Health Advisory” that cautioned about the risks associated with the whole new generation of antidepressants including Prozac and its knock offs, Zoloft, Paxil, Luvox, Celexa, and Lexapro, as well as Wellbutrin, Effexor, Serzone, and Remeron. The warning followed a public hearing where dozens of family members and victims testified about suicide and violence committed by individuals taking these medications. Read the rest of this entry »

Abilify (Aripiprazole): Lawsuit Settlement – Serious Side Effects – NOT FDA Approved in Children and Seniors

43 States have received millions of dollars in settlements from Bristol-Myers Squibb for the questionable marketing and pricing of certain prescription drugs for the poor.

Bristol-Meyers Squibb and its former subsidiary, Apothecon Inc., agreed in September to pay a total of $499 million, according to a spokeswoman for the company. The payments to the individual states, like Georgia’s Medicaid program went out in July 2008.

“The allegations were that these companies not only engaged in a pattern of kickbacks and false reporting to drive up both the sales and prices for its drugs, they also encouraged health care providers to prescribe a potent drug to both children and seniors for uses that had not been approved by the FDA,” Georgia Attorney General Thurbert Baker said in a prepared statement. “The drive to make certain that the bottom-line meets Wall Street expectations can never justify defrauding the taxpayers or putting our most vulnerable citizens at risk.” Read the rest of this entry »